BR9407079A - Imidazois tri-substituídos possuindo múltiplas propriedades terapêuticas - Google Patents

Imidazois tri-substituídos possuindo múltiplas propriedades terapêuticas

Info

Publication number: BR9407079A
Authority: BR; Brazil
Prior art keywords: imidazois; tri; substituted; therapeutic properties; multiple therapeutic
Prior art date: 1993-07-16

Application number

BR9407079A

Other languages

English (en)

Inventor

Jerry Leroy Adams

Peter William Sheldrake

Timothy Francis Gallagher

Ravi Shanker Garigipati

Paul Elliot Bender

Jeffrey Charles Boehm

Original Assignee

Smithkline Beckman Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-07-16

Filing date

1994-07-15

Publication date

1996-08-27

1994-07-15 Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp

1996-08-27 Publication of BR9407079A publication Critical patent/BR9407079A/pt

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Physical Education & Sports Medicine (AREA)
Diabetes (AREA)
Pulmonology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Virology (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Neurology (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Obesity (AREA)
Immunology (AREA)
Emergency Medicine (AREA)
Tropical Medicine & Parasitology (AREA)
Molecular Biology (AREA)
AIDS & HIV (AREA)
Hospice & Palliative Care (AREA)
Toxicology (AREA)
Endocrinology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)

BR9407079A 1993-07-16 1994-07-15 Imidazois tri-substituídos possuindo múltiplas propriedades terapêuticas BR9407079A (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US9273393A	1993-07-16	1993-07-16
PCT/US1994/007969 WO1995002591A1 (en)	1993-07-16	1994-07-15	Tri-substituted imidazoles having multiple therapeutic properties

Publications (1)

Publication Number	Publication Date
BR9407079A true BR9407079A (pt)	1996-08-27

Family

ID=22234840

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
BR9407079A BR9407079A (pt)	1993-07-16	1994-07-15	Imidazois tri-substituídos possuindo múltiplas propriedades terapêuticas
BR1100546-7A BR1100546A (pt)	1993-07-16	1997-05-13	Compostos e composições de piridil imidazol.

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
BR1100546-7A BR1100546A (pt)	1993-07-16	1997-05-13	Compostos e composições de piridil imidazol.

Country Status (31)

Country	Link
EP (5)	EP1291346B1 (pt)
JP (4)	JPH09500137A (pt)
CN (2)	CN1050126C (pt)
AP (1)	AP484A (pt)
AT (2)	ATE236896T1 (pt)
AU (1)	AU694130C (pt)
BR (2)	BR9407079A (pt)
CA (1)	CA2167311A1 (pt)
CZ (1)	CZ11996A3 (pt)
DE (2)	DE69432463T2 (pt)
DK (1)	DK0708768T3 (pt)
DZ (1)	DZ1798A1 (pt)
ES (2)	ES2237650T3 (pt)
FI (1)	FI960177A0 (pt)
HK (3)	HK1049658A1 (pt)
HU (1)	HUT75313A (pt)
IL (2)	IL110296A (pt)
MA (1)	MA23270A1 (pt)
MY (1)	MY116478A (pt)
NO (4)	NO316881B1 (pt)
NZ (2)	NZ329994A (pt)
PL (4)	PL181721B1 (pt)
PT (1)	PT708768E (pt)
RU (1)	RU2140918C1 (pt)
SG (1)	SG52368A1 (pt)
SI (1)	SI0708768T1 (pt)
SK (1)	SK282342B6 (pt)
TW (1)	TW330934B (pt)
UA (1)	UA63875C2 (pt)
WO (1)	WO1995002591A1 (pt)
ZA (1)	ZA945193B (pt)

Families Citing this family (93)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3857751A (en) *	1971-11-15	1974-12-31	Tufdura Ltd	Composite sheet capable of withstanding impingement by particulate materials
US5916891A (en)	1992-01-13	1999-06-29	Smithkline Beecham Corporation	Pyrimidinyl imidazoles
US5840746A (en) *	1993-06-24	1998-11-24	Merck Frosst Canada, Inc.	Use of inhibitors of cyclooxygenase in the treatment of neurodegenerative diseases
US5593992A (en) *	1993-07-16	1997-01-14	Smithkline Beecham Corporation	Compounds
US5670527A (en) *	1993-07-16	1997-09-23	Smithkline Beecham Corporation	Pyridyl imidazole compounds and compositions
US5616601A (en) *	1994-07-28	1997-04-01	Gd Searle & Co	1,2-aryl and heteroaryl substituted imidazolyl compounds for the treatment of inflammation
US6613789B2 (en)	1994-07-28	2003-09-02	G. D. Searle & Co.	Heterocyclo-substituted imidazoles for the treatment of inflammation
FI972970A7 (fi) *	1995-01-12	1997-09-11	Smithkline Beecham Corp	Uusia yhdisteitä
GB9500580D0 (en) *	1995-01-12	1995-03-01	Merck Sharp & Dohme	Therapeutic agents
EP0809492A4 (en) *	1995-02-17	2007-01-24	Smithkline Beecham Corp	IL-8 RECEPTOR ANTAGONISTS
US6369068B1 (en)	1995-06-07	2002-04-09	Smithkline Beecham Corporation	Amino substituted pyrimidine containing compounds
IL118544A (en)	1995-06-07	2001-08-08	Smithkline Beecham Corp	History of imidazole, the process for their preparation and the pharmaceutical preparations containing them
US5739143A (en) *	1995-06-07	1998-04-14	Smithkline Beecham Corporation	Imidazole compounds and compositions
US6083949A (en) *	1995-10-06	2000-07-04	Merck & Co., Inc.	Substituted imidazoles having anti-cancer and cytokine inhibitory activity
US5717100A (en) *	1995-10-06	1998-02-10	Merck & Co., Inc.	Substituted imidazoles having anti-cancer and cytokine inhibitory activity
DE19540027A1 (de) *	1995-10-27	1997-04-30	Gruenenthal Gmbh	Substituierte Imidazolidin-2,4-dion-Verbindungen als pharmazeutische Wirkstoffe
ZA9610687B (en) *	1995-12-22	1997-09-29	Smithkline Beecham Corp	Novel synthesis.
WO1997025047A1 (en) *	1996-01-11	1997-07-17	Smithkline Beecham Corporation	Novel cycloalkyl substituded imidazoles
US6046208A (en) *	1996-01-11	2000-04-04	Smithkline Beecham Corporation	Substituted imidazole compounds
ZA97175B (en) *	1996-01-11	1997-11-04	Smithkline Beecham Corp	Novel substituted imidazole compounds.
PL187516B1 (pl) *	1996-01-11	2004-07-30	Smithkline Beecham Corp	Nowe podstawione pochodne imidazolu, sposób ich wytwarzania oraz kompozycja farmaceutyczna zawierająca te związki
AP9700912A0 (en)	1996-01-11	1997-01-31	Smithkline Beecham Corp	Novel cycloalkyl substituted imidazoles
WO1997032583A1 (en) *	1996-03-08	1997-09-12	Smithkline Beecham Corporation	Use of csaidtm compounds as inhibitors of angiogenesis
JP2000507558A (ja) *	1996-03-25	2000-06-20	スミスクライン・ビーチャム・コーポレイション	Ｃｎｓ損傷についての新規な治療
EP0906307B1 (en) *	1996-06-10	2005-04-27	Merck & Co., Inc.	Substituted imidazoles having cytokine inhibitory activity
WO1998007425A1 (en)	1996-08-21	1998-02-26	Smithkline Beecham Corporation	Imidazole compounds, compositions and use
US5945418A (en) *	1996-12-18	1999-08-31	Vertex Pharmaceuticals Incorporated	Inhibitors of p38
US6608060B1 (en)	1996-12-18	2003-08-19	Vertex Pharmaceuticals Incorporated	Inhibitors of p38
US6147080A (en) *	1996-12-18	2000-11-14	Vertex Pharmaceuticals Incorporated	Inhibitors of p38
US5929076A (en) *	1997-01-10	1999-07-27	Smithkline Beecham Corporation	Cycloalkyl substituted imidazoles
US6187799B1 (en)	1997-05-23	2001-02-13	Onyx Pharmaceuticals	Inhibition of raf kinase activity using aryl ureas
CA2294057A1 (en)	1997-06-13	1998-12-17	Smithkline Beecham Corporation	Novel pyrazole and pyrazoline substituted compounds
AU8154998A (en)	1997-06-19	1999-01-04	Smithkline Beecham Corporation	Novel aryloxy substituted pyrimidine imidazole compounds
US7301021B2 (en)	1997-07-02	2007-11-27	Smithkline Beecham Corporation	Substituted imidazole compounds
US6489325B1 (en)	1998-07-01	2002-12-03	Smithkline Beecham Corporation	Substituted imidazole compounds
TW517055B (en) *	1997-07-02	2003-01-11	Smithkline Beecham Corp	Novel substituted imidazole compounds
WO1999001452A1 (en)	1997-07-02	1999-01-14	Smithkline Beecham Corporation	Novel cycloalkyl substituted imidazoles
US6562832B1 (en)	1997-07-02	2003-05-13	Smithkline Beecham Corporation	Substituted imidazole compounds
WO1999017776A1 (en)	1997-10-08	1999-04-15	Smithkline Beecham Corporation	Novel cycloalkenyl substituted compounds
EP1021173A1 (en) *	1997-10-10	2000-07-26	Imperial College Innovations Limited	Use of csaid?tm compounds for the management of uterine contractions
JP3337992B2 (ja) *	1997-11-04	2002-10-28	ファイザー製薬株式会社	５−置換ピコリン酸化合物及びその製造方法
WO1999032121A1 (en) *	1997-12-19	1999-07-01	Smithkline Beecham Corporation	Compounds of heteroaryl substituted imidazole, their pharmaceutical compositions and uses
US7517880B2 (en)	1997-12-22	2009-04-14	Bayer Pharmaceuticals Corporation	Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
US7329670B1 (en)	1997-12-22	2008-02-12	Bayer Pharmaceuticals Corporation	Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
GB9809869D0 (en) *	1998-05-09	1998-07-08	Medical Res Council	Inhibition of protein kinases
CN1548436A (zh)	1998-05-22	2004-11-24	ʷ��˿��ȳ�ķ��޹�˾	新的2-烷基取代咪唑化合物
US6858617B2 (en)	1998-05-26	2005-02-22	Smithkline Beecham Corporation	Substituted imidazole compounds
EP1109918B1 (en)	1998-06-24	2006-10-04	University of Dundee	Mitogen- and stress-activated protein kinases that contain two kinase domains and uses thereof
WO2000001688A1 (en) *	1998-07-02	2000-01-13	Sankyo Company, Limited	Five-membered heteroaryl compounds
US6207687B1 (en) *	1998-07-31	2001-03-27	Merck & Co., Inc.	Substituted imidazoles having cytokine inhibitory activity
JP2003525201A (ja) *	1998-08-20	2003-08-26	スミスクライン・ビーチャム・コーポレイション	新規な置換トリアゾール化合物
WO2000025791A1 (en)	1998-11-04	2000-05-11	Smithkline Beecham Corporation	Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines
US6239279B1 (en)	1998-12-16	2001-05-29	Smithkline Beecham Corporation	Synthesis for 4-aryl-5-pyrimidine imidazole substituted derivatives
ATE538794T1 (de)	1999-01-13	2012-01-15	Bayer Healthcare Llc	Gamma carboxyarylsubstituierte diphenylharnstoffverbindungen als p38 kinasehemmer
US8124630B2 (en)	1999-01-13	2012-02-28	Bayer Healthcare Llc	ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7351834B1 (en)	1999-01-13	2008-04-01	Bayer Pharmaceuticals Corporation	ω-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US20020065296A1 (en)	1999-01-13	2002-05-30	Bayer Corporation	Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors
WO2000042012A1 (en)	1999-01-13	2000-07-20	Bayer Corporation	φ-CARBOXYARYL SUBSTITUTED DIPHENYL UREAS AS RAF KINASE INHIBITORS
US7122666B2 (en)	1999-07-21	2006-10-17	Sankyo Company, Limited	Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses
ATE305787T1 (de)	1999-11-23	2005-10-15	Smithkline Beecham Corp	3,4-dihydro-(1h)chinazolin-2-on-verbindungen als csbp/p39-kinase-inhibitoren
US6759410B1 (en)	1999-11-23	2004-07-06	Smithline Beecham Corporation	3,4-dihydro-(1H)-quinazolin-2-ones and their use as CSBP/p38 kinase inhibitors
AU1781601A (en)	1999-11-23	2001-06-04	Smithkline Beecham Corporation	3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors
EP1233951B1 (en)	1999-11-23	2005-06-01	SmithKline Beecham Corporation	3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors
US7235551B2 (en)	2000-03-02	2007-06-26	Smithkline Beecham Corporation	1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
US6627647B1 (en)	2000-03-23	2003-09-30	Boehringer Ingelheim Pharmaceuticals, Inc.	Substituted 1-(4-aminophenyl)imidazoles and their use as anti-inflammatory agents
GB0021726D0 (en) *	2000-09-05	2000-10-18	Astrazeneca Ab	Chemical compounds
US7235576B1 (en)	2001-01-12	2007-06-26	Bayer Pharmaceuticals Corporation	Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
ITMI20010206A1 (it) *	2001-02-02	2002-08-02	Dompe Spa	Uso della metansolfonammide di (r)-ibuprofene e dei suoi sali non tossici per la preparazione di medicamenti per il trattamento e la prevenz
US7371763B2 (en)	2001-04-20	2008-05-13	Bayer Pharmaceuticals Corporation	Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
FR2823747B1 (fr) *	2001-04-24	2003-05-23	Oreal	Nouveaux composes de la famille des 3-alkyl-(4,5 diphenyl- imidazol-1-yl) et leur utilisation comme anti-inflammatoires
FR2823751B1 (fr) *	2001-04-24	2003-05-23	Oreal	Nouveaux composes de la famille des 3-alkyl-(4,5 diphenyl- imidazol-1-yl) et leur utilisation comme anti-inflammatoires
WO2002094267A1 (en) *	2001-05-24	2002-11-28	Sankyo Company, Limited	Pharmaceutical composition for prevention or treatment of arthritis
MXPA04007832A (es)	2002-02-11	2005-09-08	Bayer Pharmaceuticals Corp	Aril-ureas con actividad inhibitoria de angiogenesis.
MXPA04007830A (es)	2002-02-11	2005-07-01	Bayer Pharmaceuticals Corp	Arilureas como inhibidores de cinasa.
RU2217196C2 (ru) *	2002-02-28	2003-11-27	Небольсин Владимир Евгеньевич	Способ индукции дифференцировки клеток
JP4481011B2 (ja)	2002-03-05	2010-06-16	トランステックファーマ，インコーポレイテッド	リガンドのｒａｇｅとの相互作用を阻害する単環式および二環式アゾール誘導体
AR039241A1 (es)	2002-04-04	2005-02-16	Biogen Inc	Heteroarilos trisustituidos y metodos para su produccion y uso de los mismos
EP1499305A2 (en) *	2002-04-12	2005-01-26	Pfizer Japan Inc.	Use of ep4 receptor ligands in the treatment of il-6 involved diseases
ATE479683T1 (de)	2002-11-05	2010-09-15	Glaxo Group Ltd	Antibakterielle mittel
WO2004113274A2 (en)	2003-05-20	2004-12-29	Bayer Pharmaceuticals Corporation	Diaryl ureas with kinase inhibiting activity
EA010485B1 (ru)	2003-07-23	2008-10-30	Байер Фамэсьютиклс Копэрейшн	Производное n,n'-дифенилмочевины, фармацевтическая композиция (варианты) и способ лечения и предупреждения заболеваний и состояний с его использованием (варианты)
TWI381841B (zh) *	2005-03-11	2013-01-11	Zenyaku Kogyo Kk	An immunosuppressive agent and an antitumor agent containing a heterocyclic compound as an active ingredient
CN101137656B (zh) *	2005-03-11	2010-12-22	拉夸里亚创药株式会社	咪唑衍生物的晶型
RU2297839C1 (ru) *	2005-10-10	2007-04-27	Всероссийский научно-исследовательский институт пантового оленеводства (ВНИИПО)	Лекарственное средство для лечения актиномикоза
ES2467923T3 (es)	2009-09-30	2014-06-13	Transtech Pharma, Llc	Derivados de imidazol substituidos para el tratamiento de la enfermedad de Alzheimer
SI2493876T1 (sl)	2009-10-28	2014-04-30	Pfizer Inc.	Derivati imidazola kot inhibitorji kazein-kinaze
RU2418582C1 (ru) *	2010-04-08	2011-05-20	Аверин Константин Михайлович	1,3-диалкилбензимидазолия галогениды - средства для лечения рассеянного склероза
CN104387301B (zh) *	2014-11-11	2016-05-04	常州大学	一种2-氟-4-甲基苯磺酰甲基异腈的合成方法
CN107847480B (zh)	2015-03-23	2021-06-25	墨尔本大学	呼吸性疾病的治疗
PT3619204T (pt) *	2017-05-03	2025-10-29	Tianli Biotech Pty Ltd	Compostos para o tratamento de doenças respiratórias
JP7575099B2 (ja)	2018-11-07	2024-10-29	ティアンリバイオテックプロプライエタリリミテッド	呼吸器疾患の処理のための新規な化合物
CN110531023B (zh) *	2019-10-08	2024-06-14	安徽理工大学	一种薄层色谱分析仪
CN114112812B (zh) *	2021-10-29	2024-05-24	华北电力大学	相变颗粒测试装置、固-液相变机理可视化实验台及方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3707475A (en) *	1970-11-16	1972-12-26	Pfizer	Antiinflammatory imidazoles
US3929807A (en) *	1971-05-10	1975-12-30	Ciba Geigy Corp	2-Substituted-4(5)-(aryl)-5(4)-(2,3 or -4-pyridyl)-imidazoles
DE2242454A1 (de) *	1972-08-29	1974-03-07	Bayer Ag	1-aethyl-imidazole, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
IL95880A (en) *	1989-10-13	1995-12-31	Pfizer	Use of 3-Transformed History of 2-Oxindole for the Preparation of Pharmaceuticals for Inhibition of Interlaukio-1 Biosynthesis
JPH06504779A (ja) *	1990-12-13	1994-06-02	スミスクライン・ビーチャム・コーポレイション	新規ｃｓａｉｄｓ
IE914327A1 (en) *	1990-12-13	1992-06-17	Smithkline Beecham Corp	Novel csaids
MX9300141A (es) *	1992-01-13	1994-07-29	Smithkline Beecham Corp	Compuestos de imidazol novedosos, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.

1994
- 1994-07-12 IL IL11029694A patent/IL110296A/xx not_active IP Right Cessation
- 1994-07-13 AP APAP/P/1994/000654A patent/AP484A/en active
- 1994-07-13 DZ DZ940081A patent/DZ1798A1/fr active
- 1994-07-14 MY MYPI94001844A patent/MY116478A/en unknown
- 1994-07-14 MA MA23584A patent/MA23270A1/fr unknown
- 1994-07-15 EP EP02079534A patent/EP1291346B1/en not_active Expired - Lifetime
- 1994-07-15 EP EP94923503A patent/EP0708768B1/en not_active Expired - Lifetime
- 1994-07-15 PL PL94332408A patent/PL181721B1/pl unknown
- 1994-07-15 CA CA002167311A patent/CA2167311A1/en not_active Abandoned
- 1994-07-15 PL PL94332405A patent/PL181723B1/pl unknown
- 1994-07-15 JP JP7504744A patent/JPH09500137A/ja active Pending
- 1994-07-15 DE DE69432463T patent/DE69432463T2/de not_active Expired - Fee Related
- 1994-07-15 HU HU9503855A patent/HUT75313A/hu unknown
- 1994-07-15 EP EP02076580A patent/EP1227091A3/en not_active Withdrawn
- 1994-07-15 EP EP02076582A patent/EP1227092A3/en not_active Withdrawn
- 1994-07-15 PT PT94923503T patent/PT708768E/pt unknown
- 1994-07-15 SI SI9430449T patent/SI0708768T1/xx unknown
- 1994-07-15 NZ NZ329994A patent/NZ329994A/xx unknown
- 1994-07-15 ES ES02079534T patent/ES2237650T3/es not_active Expired - Lifetime
- 1994-07-15 EP EP02076581A patent/EP1229035A1/en not_active Withdrawn
- 1994-07-15 DE DE69434316T patent/DE69434316T2/de not_active Expired - Fee Related
- 1994-07-15 ES ES94923503T patent/ES2197167T3/es not_active Expired - Lifetime
- 1994-07-15 NZ NZ269457A patent/NZ269457A/en unknown
- 1994-07-15 PL PL94332406A patent/PL181694B1/pl unknown
- 1994-07-15 DK DK94923503T patent/DK0708768T3/da active
- 1994-07-15 CN CN94193161A patent/CN1050126C/zh not_active Expired - Fee Related
- 1994-07-15 WO PCT/US1994/007969 patent/WO1995002591A1/en not_active Ceased
- 1994-07-15 AT AT94923503T patent/ATE236896T1/de not_active IP Right Cessation
- 1994-07-15 RU RU96103386/04A patent/RU2140918C1/ru not_active IP Right Cessation
- 1994-07-15 AT AT02079534T patent/ATE291576T1/de not_active IP Right Cessation
- 1994-07-15 FI FI960177A patent/FI960177A0/fi unknown
- 1994-07-15 SG SG1996003561A patent/SG52368A1/en unknown
- 1994-07-15 BR BR9407079A patent/BR9407079A/pt not_active Application Discontinuation
- 1994-07-15 SK SK47-96A patent/SK282342B6/sk unknown
- 1994-07-15 CZ CZ96119A patent/CZ11996A3/cs unknown
- 1994-07-15 ZA ZA945193A patent/ZA945193B/xx unknown
- 1994-07-15 AU AU73354/94A patent/AU694130C/en not_active Ceased
- 1994-07-15 PL PL94312614A patent/PL181705B1/pl unknown
- 1994-07-15 UA UA96010110A patent/UA63875C2/uk unknown
- 1994-10-04 TW TW083109192A patent/TW330934B/zh active
1996
- 1996-01-15 NO NO960173A patent/NO316881B1/no not_active IP Right Cessation
1997
- 1997-05-13 BR BR1100546-7A patent/BR1100546A/pt active IP Right Grant
1998
- 1998-05-04 IL IL12431898A patent/IL124318A0/xx unknown
- 1998-06-17 CN CN98115012A patent/CN1218801A/zh active Pending
- 1998-12-16 HK HK03100349.5A patent/HK1049658A1/en unknown
- 1998-12-16 HK HK03100345.9A patent/HK1049657A1/en unknown
- 1998-12-16 HK HK03100350.1A patent/HK1049659A1/en unknown
2001
- 2001-02-19 NO NO20010838A patent/NO20010838D0/no not_active Application Discontinuation
- 2001-02-19 NO NO20010837A patent/NO20010837D0/no not_active Application Discontinuation
- 2001-02-19 NO NO20010839A patent/NO20010839D0/no not_active Application Discontinuation
2003
- 2003-12-10 JP JP2003412024A patent/JP2004149541A/ja active Pending
- 2003-12-10 JP JP2003412029A patent/JP2004099622A/ja active Pending
- 2003-12-10 JP JP2003412020A patent/JP2004083600A/ja active Pending

Also Published As

Publication number	Publication date
AU694130B2 (en)	1998-07-16
DZ1798A1 (fr)	2002-02-17
EP0708768B1 (en)	2003-04-09
DE69432463D1 (de)	2003-05-15
WO1995002591A1 (en)	1995-01-26
NO10837A (no)	1996-01-15
EP1227091A2 (en)	2002-07-31
CN1129447A (zh)	1996-08-21
TW330934B (en)	1998-05-01
NO20010837D0 (no)	2001-02-19
AP484A (en)	1996-04-23
ZA945193B (en)	1995-04-20
NO316881B1 (no)	2004-06-14
SI0708768T1 (en)	2003-10-31
AU705568B2 (en)	1999-05-27
DE69434316D1 (de)	2005-04-28
NO960173L (no)	1996-01-15
DE69432463T2 (de)	2004-02-12
JP2004083600A (ja)	2004-03-18
PL312614A1 (en)	1996-04-29
CZ11996A3 (en)	1996-10-16
FI960177L (fi)	1996-01-15
UA63875C2 (en)	2004-02-16
EP1227092A3 (en)	2002-08-07
RU2140918C1 (ru)	1999-11-10
ES2237650T3 (es)	2005-08-01
NO20010839D0 (no)	2001-02-19
JPH09500137A (ja)	1997-01-07
NO20010838D0 (no)	2001-02-19
AU7185098A (en)	1998-08-27
SK282342B6 (sk)	2002-01-07
PL181705B1 (pl)	2001-09-28
NO10839A (no)	1996-01-15
NZ329994A (en)	1999-07-29
DK0708768T3 (da)	2003-08-04
HK1012392A1 (en)	1999-07-30
CA2167311A1 (en)	1995-01-26
EP0708768A1 (en)	1996-05-01
EP1227092A2 (en)	2002-07-31
JP2004099622A (ja)	2004-04-02
SK4796A3 (en)	1997-01-08
PT708768E (pt)	2003-08-29
FI960177A7 (fi)	1996-01-15
AU694130C (en)	2002-12-05
EP1291346B1 (en)	2005-03-23
AP9400654A0 (en)	1994-07-31
ATE291576T1 (de)	2005-04-15
NZ269457A (en)	1998-08-26
HK1049659A1 (en)	2003-05-23
IL110296A0 (en)	1994-10-21
NO960173D0 (no)	1996-01-15
FI960177A0 (fi)	1996-01-15
PL181723B1 (pl)	2001-09-28
HK1049658A1 (en)	2003-05-23
IL110296A (en)	1999-12-31
MY116478A (en)	2004-02-28
CN1218801A (zh)	1999-06-09
EP0708768A4 (en)	1996-08-21
HUT75313A (en)	1997-05-28
MA23270A1 (fr)	1995-04-01
AU7335494A (en)	1995-02-13
PL181721B1 (en)	2001-09-28
HU9503855D0 (en)	1996-02-28
EP1291346A1 (en)	2003-03-12
NO10838A (no)	1996-01-15
EP1229035A1 (en)	2002-08-07
ES2197167T3 (es)	2004-01-01
BR1100546A (pt)	2004-08-31
PL181694B1 (pl)	2001-09-28
ATE236896T1 (de)	2003-04-15
SG52368A1 (en)	1998-09-28
CN1050126C (zh)	2000-03-08
DE69434316T2 (de)	2006-03-09
JP2004149541A (ja)	2004-05-27
EP1227091A3 (en)	2002-08-07
HK1049657A1 (en)	2003-05-23
IL124318A0 (en)	1998-12-06

Legal Events

Date	Code	Title	Description
1998-05-12	FA	Application withdrawn

Publication	Publication Date	Title
BR9407079A (pt)	1996-08-27	Imidazois tri-substituídos possuindo múltiplas propriedades terapêuticas
DE69424027D1 (de)	2000-05-25	Katheter
NO944047D0 (no)	1994-10-24	Strömningsledet kateter
FI945690L (fi)	1995-06-03	Substituoitu N-piperidino-3-pyratsolikarboksamidi
DE69423046D1 (de)	2000-03-23	Schnellzurückziehbarer katheter
FI940154L (fi)	1994-07-16	Substituoidut dialkyylitioeetterit
FI932094A0 (fi)	1993-05-07	Kylningsapparat i kranens vaexel
DE59403503D1 (de)	1997-09-04	Substituierte 1-Aryltriazolinone
BR9406092A (pt)	1995-12-12	Cateter
FI932732A0 (fi)	1993-06-15	Rotorkonstruktion i en tvaolindningselektricitetsmaskin
FI932264A0 (fi)	1993-05-18	Gapformare i en pappersmaskin
FI956304L (fi)	1996-01-25	Substituoidut aryltioalkyylitiopyridiinit
FI962301A7 (fi)	1996-05-31	Substituoidut aminoalkyyliaminopyridiinit
BR9405830A (pt)	1996-01-16	Oxazois substituidos
FI930927A0 (fi)	1993-03-02	Banformningsparti i en pappersmaskin
IT230757Y1 (it)	1999-07-05	Cannula per fleboipodermoclisi
KR950005495U (ko)	1995-03-20	조립식 가구
BR9403277A (pt)	1995-04-11	Colhedeira estreita
IT230756Y1 (it)	1999-07-05	Cannula per fleboipodermoclisi
SE9301988D0 (sv)	1993-06-10	Staal
KR950000395U (ko)	1995-01-03	장갑형 때밀이 타올
ITMI931038A0 (it)	1993-05-20	Densostato multiplo
BR9301563A (pt)	1994-11-08	Generoso - bem bolado
KR940022970U (ko)	1994-10-20	조립식 가구
FI923U1 (fi)	1993-09-29	Anordning foer konstant bevattning